Prof. Dr. med. Peter Fasching

Professur für Translationale Frauenheilkunde und Geburtshilfe

A content-based review of mobile health applications for breast cancer prevention and education: Characteristics, quality and functionality analysis (2024) Altmannshofer S, Flaucher M, Beierlein M, Eskofier B, Beckmann M, Fasching P, Hübner H Journal article, Review article Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells - The DETECT III Clinical Trial (2024) Fehm T, Mueller V, Banys-Paluchowski M, Fasching P, Friedl TW, Hartkopf A, Huober J, et al. Journal article Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negative breast cancer (2024) Heger L, Heidkamp GF, Amon L, Nimmerjahn F, Bäuerle T, Maier A, Erber R, et al. Journal article Perspectives of patients and clinicians on big data and AI in health: a comparative empirical investigation (2024) Hummel P, Braun M, Bischoff S, Samhammer D, Seitz K, Fasching P, Dabrock P Journal article Status quo and future directions of digitalization in gynecology and obstetrics in Germany: a survey of the commission Digital Medicine of the German Society for Gynecology and Obstetrics (2024) Pfob A, Hillen C, Seitz K, Griewing S, Becker S, Bayer C, Wagner U, et al. Journal article Usability and Perception of a Wearable-Integrated Digital Maternity Record App in Germany: User Study (2023) Nissen M, Perez CA, Jäger K, Bleher H, Flaucher M, Hübner H, Danzberger N, et al. Journal article Current landscape of hospital information systems in gynecology and obstetrics in Germany: a survey of the commission Digital Medicine of the German Society for Gynecology and Obstetrics (2023) Pfob A, Griewing S, Seitz K, Hillen C, Becker S, Bayer C, Wagner U, et al. Journal article Favorable impact of therapy management by an interactive eHealth system on severe adverse events in patients with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer treated by palbociclib and endocrine therapy (2023) Harbeck N, Kates R, Schinköthe T, Schumacher J, Wuerstlein R, Degenhardt T, Lüftner D, et al. Journal article, Review article Prevalence and course of pregnancy symptoms using self-reported pregnancy app symptom tracker data (2023) Nissen M, Barrios Campo N, Flaucher M, Jäger K, Titzmann A, Blunck D, Fasching P, et al. Journal article, Original article Genomic analysis of advanced breast cancer tumors from talazoparib-treated gBRCA1/2mut carriers in the ABRAZO study (2023) Turner NC, Laird AD, Telli ML, Rugo HS, Mailliez A, Ettl J, Grischke EM, et al. Journal article